BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34233927)

  • 1. Modification of the Association Between Severe Hypoglycemia and Ischemic Heart Disease by Surrogates of Vascular Damage Severity in Type 1 Diabetes During ∼30 Years of Follow-up in the DCCT/EDIC Study.
    Fahrmann ER; Adkins L; Driscoll HK
    Diabetes Care; 2021 Sep; 44(9):2132-2139. PubMed ID: 34233927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study.
    Fährmann ER; Adkins L; Loader CJ; Han H; Rice KM; Denvir J; Driscoll HK
    Diabetes Res Clin Pract; 2015 Feb; 107(2):280-9. PubMed ID: 25467622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of severe hypoglycemia and possible associated factors in pediatric patients with type 1 diabetes in the real-life, post-Diabetes Control and Complications Trial setting: A systematic review.
    Cherubini V; Rabbone I; Lombardo F; Mossetto G; Orsini Federici M; Nicolucci A
    Pediatr Diabetes; 2019 Sep; 20(6):678-692. PubMed ID: 31177592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to Comment on Fahrmann et al. Modification of the Association Between Severe Hypoglycemia and Ischemic Heart Disease by Surrogates of Vascular Damage Severity in Type 1 Diabetes During ∼30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2021;44;2132-2139.
    Fahrmann ER; Driscoll HK
    Diabetes Care; 2022 Mar; 45(3):e65-e66. PubMed ID: 35245357
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study.
    Hainsworth DP; Bebu I; Aiello LP; Sivitz W; Gubitosi-Klug R; Malone J; White NH; Danis R; Wallia A; Gao X; Barkmeier AJ; Das A; Patel S; Gardner TW; Lachin JM;
    Diabetes Care; 2019 May; 42(5):875-882. PubMed ID: 30833368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment on Fahrmann et al. Modification of the Association Between Severe Hypoglycemia and Ischemic Heart Disease by Surrogates of Vascular Damage Severity in Type 1 Diabetes During ∼30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2021;44;2132-2139.
    González-Clemente JM; Llauradó G; Romero A; Giménez-Palop O; Berlanga E; Vendrell J
    Diabetes Care; 2022 Mar; 45(3):e63-e64. PubMed ID: 35245354
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study.
    Gubitosi-Klug RA; Braffett BH; White NH; Sherwin RS; Service FJ; Lachin JM; Tamborlane WV;
    Diabetes Care; 2017 Aug; 40(8):1010-1016. PubMed ID: 28550194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort.
    Klein RL; McHenry MB; Lok KH; Hunter SJ; Le NA; Jenkins AJ; Zheng D; Semler A; Page G; Brown WV; Lyons TJ; Garvey WT;
    J Diabetes Complications; 2005; 19(1):18-25. PubMed ID: 15642486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes.
    Gubitosi-Klug R; Gao X; Pop-Busui R; de Boer IH; White N; Aiello LP; Miller R; Palmer J; Tamborlane W; Wallia A; Kosiborod M; Lachin JM; Bebu I;
    Diabetes Care; 2021 Jul; 44(7):1499-1505. PubMed ID: 33980605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular Autonomic Neuropathy and Cardiovascular Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
    Pop-Busui R; Braffett BH; Zinman B; Martin C; White NH; Herman WH; Genuth S; Gubitosi-Klug R;
    Diabetes Care; 2017 Jan; 40(1):94-100. PubMed ID: 27803120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of digital and film grading of diabetic retinopathy severity in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Hubbard LD; Sun W; Cleary PA; Danis RP; Hainsworth DP; Peng Q; Susman RA; Aiello LP; Davis MD;
    Arch Ophthalmol; 2011 Jun; 129(6):718-26. PubMed ID: 21670338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and peripheral vascular disease.
    Huysman E; Mathieu C
    Acta Chir Belg; 2009 Oct; 109(5):587-94. PubMed ID: 19994800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up.
    Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group
    Diabetes Care; 2016 May; 39(5):686-93. PubMed ID: 26861924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).
    Pop-Busui R; Low PA; Waberski BH; Martin CL; Albers JW; Feldman EL; Sommer C; Cleary PA; Lachin JM; Herman WH;
    Circulation; 2009 Jun; 119(22):2886-93. PubMed ID: 19470886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study.
    Bebu I; Schade D; Braffett B; Kosiborod M; Lopes-Virella M; Soliman EZ; Herman WH; Bluemke DA; Wallia A; Orchard T; Lachin JM;
    Diabetes Care; 2020 Apr; 43(4):867-874. PubMed ID: 32001614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association of Coronary Artery Calcification With Subsequent Incidence of Cardiovascular Disease in Type 1 Diabetes: The DCCT/EDIC Trials.
    Budoff M; Backlund JC; Bluemke DA; Polak J; Bebu I; Schade D; Strowig S; Raskin P; Lachin JM;
    JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 2):1341-1349. PubMed ID: 30878435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factor Modeling for Cardiovascular Disease in Type 1 Diabetes in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study: A Comparison With the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC).
    Miller RG; Costacou T; Orchard TJ
    Diabetes; 2019 Feb; 68(2):409-419. PubMed ID: 30409781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors for Longitudinal Resting Heart Rate and Its Associations With Cardiovascular Outcomes in the DCCT/EDIC Study.
    Keshavarzi S; Braffett BH; Pop-Busui R; Orchard TJ; Soliman EZ; Lorenzi GM; Barnie A; Karger AB; Gubitosi-Klug RA; Dagogo-Jack S; Paterson AD;
    Diabetes Care; 2021 May; 44(5):1125-1132. PubMed ID: 33632724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe hypoglycemia and diabetic ketoacidosis in young persons with preschool onset of type 1 diabetes mellitus: An analysis of three nationwide population-based surveys.
    Lindner LME; Gontscharuk V; Bächle C; Castillo K; Stahl-Pehe A; Tönnies T; Yossa R; Holl RW; Rosenbauer J
    Pediatr Diabetes; 2018 Jun; 19(4):713-720. PubMed ID: 29498171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.